September 30, 2025

agilon health, inc. (AGL) Stock Analysis: Eyeing a 33.75% Upside in a Challenging Market Landscape

agilon health, inc. (NYSE: AGL) is a player in the healthcare sector, specifically within the medical care facilities industry. Based in Westerville, Ohio, the company focuses on providing healthcare services..

U.S. Physical Therapy, Inc. (USPH): Investor Outlook on Strong Revenue Growth and Upside Potential

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, is making waves with its impressive revenue growth and a substantial potential upside of 28.14%. Headquartered in..

Evolent Health, Inc. (EVH) Stock Analysis: A Potential 76% Upside with Strong Buy Ratings

Evolent Health, Inc. (NYSE: EVH), a key player in the healthcare sector, is garnering significant attention from investors with its focus on specialty care management services in areas such as..

Harrow, Inc. (HROW) Stock Analysis: A 37% Potential Upside Captivates Investors

In the bustling realm of the healthcare sector, Harrow, Inc. (NASDAQ: HROW) stands out as a burgeoning player in the specialty and generic drug manufacturing industry. With its focus on..

Pacira BioSciences, Inc. (PCRX) Investor Outlook: A 14.44% Upside Amidst Healthcare Innovations

Pacira BioSciences, Inc. (NASDAQ: PCRX), a prominent player in the healthcare sector, stands at the forefront of non-opioid pain management solutions. With a market capitalization of $1.14 billion, this Tampa-based..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A Biotech Prospect with a 222% Upside Potential

Investors looking for promising opportunities in the biotechnology sector may find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) an intriguing prospect. With a market capitalization of $968.5 million, this San Diego-based company..

Immunocore Holdings plc (IMCR) Growth Potential: Analyst Ratings Suggest an 81% Upside

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology company, has captured investor attention with its promising pipeline of immunotherapies targeting cancer, infectious, and autoimmune diseases. As the healthcare sector continues..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: 178.4% Potential Upside Sparks Investor Interest

Dyne Therapeutics, Inc. (NASDAQ: DYN) is making waves in the biotechnology sector with its ambitious approach to tackling neuromuscular diseases. This clinical-stage company, headquartered in Waltham, Massachusetts, is harnessing its..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 21.35% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, offers a compelling investment opportunity with a potential upside..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 55% Upside Potential

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is capturing investor attention with a robust potential upside of approximately 55.28%. Specializing in medical care facilities, Astrana Health..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Buy Ratings and 14.22% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has emerged as a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market cap of $2.05..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 76% Potential Upside in the Biotechnology Sector

Investors with an eye on the healthcare sector might want to pay close attention to MiMedx Group, Inc. (NASDAQ: MDXG), a company entrenched in the biotechnology industry. With its focus..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Unpacking a 9.16% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a notable player in the medical care facilities industry, offers a compelling investment narrative with a promising 9.16% potential upside. With a market capitalization..

The Pennant Group, Inc. (PNTG) Investor Outlook: Exploring a 33% Potential Upside

The Pennant Group, Inc. (NASDAQ: PNTG), a key player in the U.S. healthcare sector, commands attention with its focus on home health, hospice services, and senior living. Operating across several..

Novavax, Inc. (NVAX) Investor Outlook: Exploring a 45.86% Upside Potential

Novavax, Inc. (NVAX), a prominent player in the biotechnology sector, has been a focal point of attention for investors, particularly following the development and commercialization of its COVID-19 vaccine, NVX-CoV2373...

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 51% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a compelling opportunity for investors looking to capitalize on potential growth in..

Immunovant, Inc. (IMVT): Investor Outlook on a Potential 148% Upside in Biotech

Immunovant, Inc. (IMVT) stands as a notable player in the biotechnology sector, specifically focusing on the development of monoclonal antibodies to tackle autoimmune diseases. Based in New York and founded..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Unveiling a Potential 189% Upside in the Biotechnology Sector

Structure Therapeutics Inc. (NASDAQ: GPCR) is making waves in the biotechnology sector with its promising pipeline of therapeutics aimed at addressing chronic diseases with significant unmet medical needs. Headquartered in..

Teladoc Health, Inc. (TDOC) Investor Outlook: Navigating the Virtual Healthcare Frontier with an 11.28% Potential Upside

Teladoc Health, Inc. (TDOC), a key player in the ever-evolving healthcare industry, has captured the attention of investors with its robust virtual healthcare services and a notable potential upside of..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: 29.83% Upside Potential with Innovative Spinal Solutions

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the healthcare sector, specifically within the medical devices industry, has been capturing the attention of investors with its remarkable growth trajectory..

Search

Funds

September 30, 2025

Search

Funds

September 30, 2025

FTSE 100

Funds